Ahead of VA Healthcare 2019, taking place this May 13th – 15th in National Harbor, Maryland, we created a breakdown of the Department of Veterans Affairs’ total budget for 2019, which is a $12.1 billion increase from FY18. The 2019 budget includes significant reforms, internal offsets, and improved efficiencies to provide veterans with the care they deserve and improve the management of resources. The budget will fully enable VA to operate the largest integrated health care system in the country, delivering health care to over 9.3 million enrolled veterans.
This interactive presentation will guide you through the key process improvements laid out by the VA, as they work to maintain internal systems and strengthen integrated outside networks.
The VA Mission Act of 2018, signed into law by President Trump on June 6, 2018, is designed to significantly improve veteran access to VA healthcare. The VA Mission Act tackles in-network and non-VA healthcare issues, veterans’ homes, access to walk-in VA care, prescription drug procedures, and much more. The $52 billion Mission Act paves the way for a major overhaul of how the Department of Veterans Affairs provides access for veterans to receive care in the private sector.
Colonel Horvath is Board Certified in internal medicine and preventive medicine for 40 years. In this interview, he shares his opinion on the most pertinent health hazards facing combat and non-combat deployed troops today.
A lot of veteran programs worldwide face similar challenges to the U.S., often with lesser budgets. Prior to the VA Healthcare Summit in May, we have highlighted the recent developments taking place in veteran programs across the globe. This whitepaper takes a look at Canada, Singapore, Australia, the United Kingdom, and New Zealand. Glancing at the latest developments and "best practices" of other countries could help to inspire new policies for U.S. veterans.
IV catheter placement remains the most common invasive hospital procedure performed worldwide. This whitepaper summarizes the clinical research that established the operational capabilities of the ivWatch device, and formed the basis of the data submitted to the FDA in support of the ivWatch 510(k) Premarket Notification.